"We provide help and inspire hope to those affected by cancer through high quality, advanced oncology and hematology cancer treatments and leading-edge technology."

During the past decade, Northwest Georgia Oncology Centers, PCWilliam S. Gibbons Center Research Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Northwest Georgia Oncology Centers, PCWilliam S. Gibbons Center Research Institute" are "B-cell Chronic Lymphocytic Leukemia" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Northwest Georgia Oncology Centers, PCWilliam S. Gibbons Center Research Institute" in a lesser frequency.

Most popular intervention types in "Northwest Georgia Oncology Centers, PCWilliam S. Gibbons Center Research Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (1 trials), "Dexamethasone" (1 trials), "Lenalidomide" (1 trials), "Placebo" (1 trials) and "Pomalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Georgia Oncology Centers, PCWilliam S. Gibbons Center Research Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Northwest Georgia Oncology Centers, PCWilliam S. Gibbons Center Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Northwest Georgia Oncology Centers, PCWilliam S. Gibbons Center Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Georgia Oncology Centers, PCWilliam S. Gibbons Center Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".